4Q preview: AbbVie, AZ, Gilead, GSK, Lilly, Merck, Novo Nordisk and Sanofi
This article was originally published in Scrip
Executive Summary
The full year reporting season is in full swing, with Bristol-Myers Squibb, Pfizer, Amgen, Novartis and Roche, among others, having reported a mixed set of numbers this week.